NCT07533383 Effect of Anterior Iliac Block on Postoperative Analgesia and Patient Satisfaction in Inguinal Hernia Repair Surgery
| NCT ID | NCT07533383 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sanliurfa Mehmet Akif Inan Education and Research Hospital |
| Condition | Anterior Ilıac Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-04-30 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-04-30 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Inguinal hernia repair is one of the most commonly performed surgical procedures worldwide and presents challenges in anesthesia selection and postoperative pain management. Spinal anesthesia is frequently preferred due to its advantages, such as avoiding neuromuscular blockers and endotracheal intubation. Effective postoperative analgesia is essential for improving patient comfort and reducing opioid consumption. The anterior iliac block, a recently described technique, has emerged as a potential alternative to conventional regional anesthesia methods, offering wider nerve coverage and possibly improved analgesia. However, evidence regarding its efficacy and safety remains limited. This study aims to evaluate the effect of the anterior iliac block on postoperative analgesia duration and patient satisfaction in patients undergoing inguinal hernia surgery.
Eligibility Criteria
Inclusion Criteria: * 18-65 years patient * American Society of Anesthesiologists(ASA) I-II patient Exclusion Criteria: * Patients who declined to participate in the study * Patients with contraindications to the anterior iliac block * Pregnant or breastfeeding patients * Patients classified as ASA III, IV, or V
Contact & Investigator
ABDULLAH ŞENGÜL, MD
PRINCIPAL INVESTIGATOR
Şanlıurfa Mehmet Akif İnan Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07533383 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Anterior Ilıac Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07533383 currently recruiting?
Yes, NCT07533383 is actively recruiting participants. Contact the research team at abdullahsengul342@gmail.com for enrollment information.
Where is the NCT07533383 trial being conducted?
This trial is being conducted at Sanliurfa, Turkey (Türkiye), Sanliurfa, Turkey (Türkiye).
Who is sponsoring the NCT07533383 clinical trial?
NCT07533383 is sponsored by Sanliurfa Mehmet Akif Inan Education and Research Hospital. The principal investigator is ABDULLAH ŞENGÜL, MD at Şanlıurfa Mehmet Akif İnan Training and Research Hospital. The trial plans to enroll 80 participants.